Skip to main content
. 2020 Mar 11;222(3):396–406. doi: 10.1093/infdis/jiaa109

Figure 1.

Figure 1.

CD14/16 and CD14/169 monocyte activation. The monocyte CD16+ population decreased in visit 2 ([V2] 7.33%) compared with visit 1 ([V1] 12.1%) in human immunodeficiency virus (HIV)/hepatitis C virus (HCV) subjects (P = .007, paired t test). This denotes a 39.5% decrease in an inflammatory monocyte subset but no change in a monocyte interferon marker, CD169. Black bars indicate the means of each group at V1 and V2.